About this course

Calcitonin Gene-Related Peptide (CGRP) molecules released by the cerebral nerves and blood vessels are involved in the pain-associated symptoms of migraine. CGRP monoclonal antibodies are prescribed for the treatment of difficult-to-treat migraines, reducing symptoms in cases of inadequate response to medication, and even used as a preventative therapy.

In this online module, Professor Messoud Ashina uses various case studies to illustrate diagnoses and treatment of migraine according to patient specificities, including eligibility for anti-CGRP therapy. Treatment guidelines based off the International Classification of Headache Disorders, American Headache Society and European Headache Federation are shared, providing expert insight to the use of anti-CGRP in migraine management.

Sponsored by